Research Article

PLCE1 Polymorphisms and Risk of Esophageal and Gastric Cancer in a Northwestern Chinese Population

Table 2

Logistic regression of candidate tSNPs in PLCE1 and their association with EC and GC risk.

IDGenotypeCase (n = 324)Control (n = 357) Crude ORPAdjusted ORPHWE-P
No. (%)No. (%)(95%CI)(95%CI)

rs3765524CC168(51.9)223(62.6)110.896
CT136(42.0)117(32.9)1.54(1.12-2.12)0.008 1.66(1.16-2.38)0.006
TT20(6.2)16(4.5)1.66(0.83-3.30)0.1491.60(0.72-3.55)0.247
CT/TT156(48.1)133(37.4)1.56(1.15-2.11)0.005 1.65(1.17-2.34)0.004
rs3818432CC104(57.5)193(65.6)110.856
CA73(40.3)91(31.0)1.49(1.01-2.20)0.045 1.47(0.97-2.23)0.073
AA4(2.2)10(3.4)0.74(0.23-2.42)0.6220.87(0.24-3.09)0.826
CA/AA77(42.5)101(34.4)1.41(0.97-2.07)0.0741.41(0.94-2.13)0.098
rs2274223AA177(54.8)229(64.1)110.457
AG126(39.0)111(31.1)1.47(1.06-2.03)0.019 1.57(1.10-2.26)0.014
GG20(6.2)17(4.8)1.52(0.77-2.99)0.2231.43(0.66-3.14)0.367
AG/GG146(45.2)128(35.9)1.48(1.08-2.01)0.013 1.55(1.10-2.20)0.013
rs10509670AA178(54.9)229(64.5)110.391
AG124(38.3)109(30.7)1.46(1.06-2.02)0.021 1.54(1.07-2.21)0.019
GG22(6.8)17(4.8)1.66(0.86-3.23)0.1321.54(0.72-3.32)0.268
AG/GG146(45.1)126(35.5)1.49(1.10-2.03)0.011 1.54(1.09-2.18)0.014
rs11187852GG122(67.4)212(72.1)110.506
GA56(30.9)77(26.2)1.26(0.84-1.90)0.2631.33(0.85-2.07)0.212
AA3(1.7)5(1.7)1.04(0.24-4.44)0.9551.68(0.34-8.18)0.522
GA/AA59(32.6)82(27.9)1.25(0.84-1.87)0.2761.34(0.87-2.08)0.185
rs3781264TT120(66.3)206(70.1)110.511
TC58(32.0)82(27.9)1.21(0.81-1.82)0.3471.24(0.80-1.92)0.331
CC3(1.7)6(2.0)0.86(0.21-3.49)0.8311.07(0.23-5.00)0.932
TC/CC61(33.7)88(29.9)1.19(0.80-1.77)0.3901.23(0.80-1.89)0.340
rs11187866CC120(66.7)210(71.4)110.723
CG56(31.1)76(25.9)1.29(0.85-1.95)0.2261.33(0.85-2.08)0.210
GG4(2.2)8(2.7)0.88(0.26-2.97)0.8301.13(0.30-4.23)0.857
CG/GG60(33.3)84(28.6)1.25(0.84-1.86)0.2741.31(0.85-2.03)0.218

Notes. The adjusted OR is derived from the correction for age and gender. The results were in bold, if the P value < 0.05.
EC, esophageal cancer; GC, gastric cancer.